Thursday, January 03, 2013

Bad Pharma by Ben Goldacre

I have just finished Ben's latest book - Bad Pharma.  I cannot recommend it highly enough, it is a brilliant book.  It is written in 6 chapters (and an afterword) :

  • Missing Data
  • Where Do New Drugs Come From
  • Bad Regulators
  • Bad Trials
  • Bigger, Simpler Trials
  • Marketing
  • Better Data (afterword)
I found the 'Missing Data' and 'Bad Regulators' the most chilling. 

If you're reading this blog you're probably interested in robust evidence in which case you really should read Ben's book.If you're still not convinced, have a look at Ben's talk at TEDMED 2012.


2 comments:

Anne Gray said...

I have also just read Bad Pharma and it certainly opened my eyes. It should be required reading for all medical librarians who support journal clubs and/or critical appraisal training. Understanding what has not got into the literature and why, the importance of power, of cut off points and of pharma sponsorship is really important to understanding the significance of any piece of published research.
Is there anyone out there who could write "Bad Pharma - lessons for librarians"?

Anne Gray said...

I have also just read Bad Pharma and it certainly opened my eyes. It should be required reading for all medical librarians who support journal clubs and/or critical appraisal training. Understanding what has not got into the literature and why, the importance of power, of cut off points and of pharma sponsorship is really important to understanding the significance of any piece of published research.

Is there anyone out there who could write "Bad Pharma - lessons for librarians"?